Nivalis Therapeutics (NVLS) Reports Q3 Loss of $0.39/Share
Tweet
Share
E-mailGet Alerts NVLS Hot Sheet
Price: $2.40 --0%
Financial Fact:
Provision for income taxes: 6.6M
Today's EPS Names:
SFST, VLTO, CLIR, More
Financial Fact:
Provision for income taxes: 6.6M
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
Nivalis Therapeutics (NASDAQ: NVLS) reported Q3 EPS of ($0.39), versus ($7.68) reported last year.
For earnings history and earnings-related data on Nivalis Therapeutics (NVLS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- EQT Corp. (EQT) Tops Q1 EPS by 17c; offers outlook
- Avangrid (AGR) Tops Q1 EPS by 19c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
